Allopurinol riboside
CAS 16220-07-8 MFCD00057096
化学结构图
SMILES: OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1N=CC2C(=O)NC=NC1=2
化学属性
| Mol. Formula | C10H12N4O5 |
|---|---|
| Mol. Weight | 268.23 |
别名和识别编码
| Chemical Name | Allopurinol riboside |
|---|---|
| Synonym | Allopurinol riboside 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4-one |
| MDL Number | MFCD00057096 |
| PubChem Substance ID | 24890617 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Biochemicals and Reagents, Nucleoside Analogs, Nucleosides, Nucleotides, Oligonucleotides
- {SNA} Nucleoside Analogs, 核苷，核苷酸和寡核苷酸, 生化试剂
相关文献及参考
- [2]. Pacher P, et al. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006 Mar;58(1):87-114.
- [3]. Shapiro TA, et al. Pharmacokinetics and metabolism of allopurinol riboside. Clin Pharmacol Ther. 1991 May;49(5):506-14.
- [4]. Were JB, et al. Effects of probenecid on the pharmacokinetics of allopurinol riboside. Antimicrob Agents Chemother. 1993 May;37(5):1193-6.
- [1]. Nishida Y, et al. Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside. Agents Actions. 1979 Dec;9(5-6):549-52.
- [1]. Nishida Y, et al. Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside. Agents Actions. 1979 Dec;9(5-6):549-52.
- [2]. Pacher P, et al. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006 Mar;58(1):
